Treatment With RYDAPT

Approved for adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL)—collectively referred to as advanced systemic mastocytosis (SM)

Important Safety Information
Allergic Reactions
  • Do not take RYDAPT if you are allergic to midostaurin or any of the ingredients in RYDAPT
  • If you develop signs of an allergic reaction, seek medical help immediately
  • Signs of an allerg...

See More
Approved Use

RYDAPT is an oral prescription medicine used to treat adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).

 

RYDAPT is not safe when given to children in combination with chemotherapy...

See More
LEARN MORE ABOUT

A Treatment for Advanced SM

Read more to see if prescription RYDAPT® (midostaurin) capsules may be right for you.

Learn More
LEARN MORE ABOUT

Disease Information for Advanced SM

Information about advanced SM, which includes aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL).

Learn More